| 20.3 |
81.2 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 19.6 |
58.8 |
GO:0071140 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 17.0 |
17.0 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 16.3 |
65.2 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 13.9 |
83.2 |
GO:0061517 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 13.2 |
13.2 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 12.1 |
36.3 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 11.6 |
57.9 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 11.4 |
34.2 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 11.3 |
11.3 |
GO:0006850 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 10.2 |
30.6 |
GO:0021966 |
corticospinal neuron axon guidance(GO:0021966) |
| 9.9 |
39.5 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 9.9 |
39.5 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 9.7 |
9.7 |
GO:0033233 |
regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
| 9.5 |
9.5 |
GO:0097028 |
dendritic cell differentiation(GO:0097028) |
| 9.4 |
28.2 |
GO:1900226 |
negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 9.4 |
28.2 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 9.4 |
46.9 |
GO:0070829 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 9.4 |
18.7 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 9.3 |
46.6 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 9.2 |
27.7 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 8.9 |
26.6 |
GO:1904647 |
response to rotenone(GO:1904647) |
| 8.6 |
43.1 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 8.6 |
51.4 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 8.5 |
25.5 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 8.4 |
50.7 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 8.2 |
57.6 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 8.1 |
32.5 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 8.0 |
8.0 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 8.0 |
15.9 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 8.0 |
23.9 |
GO:0061364 |
apoptotic process involved in luteolysis(GO:0061364) |
| 8.0 |
63.6 |
GO:0003190 |
atrioventricular valve formation(GO:0003190) |
| 7.8 |
23.4 |
GO:1904530 |
negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 7.7 |
46.2 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 7.7 |
23.1 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 7.6 |
22.8 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 7.4 |
7.4 |
GO:1902994 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 7.4 |
44.4 |
GO:0052565 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 7.3 |
43.6 |
GO:0010734 |
protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
| 7.2 |
29.0 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 7.2 |
35.8 |
GO:0044855 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 7.1 |
21.4 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 7.0 |
21.1 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 7.0 |
112.0 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 6.9 |
13.8 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 6.7 |
26.8 |
GO:0072674 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 6.7 |
33.4 |
GO:0035633 |
maintenance of blood-brain barrier(GO:0035633) |
| 6.7 |
26.6 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 6.4 |
19.1 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 6.3 |
6.3 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 6.2 |
37.5 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 6.2 |
18.6 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 6.2 |
24.7 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 6.2 |
37.0 |
GO:0005985 |
sucrose metabolic process(GO:0005985) |
| 6.2 |
92.3 |
GO:0015669 |
gas transport(GO:0015669) oxygen transport(GO:0015671) |
| 6.2 |
24.6 |
GO:1904393 |
regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
| 6.1 |
24.6 |
GO:1902613 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 6.1 |
6.1 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 6.0 |
23.8 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 5.9 |
29.6 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 5.9 |
17.7 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 5.8 |
17.4 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 5.8 |
17.3 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 5.7 |
5.7 |
GO:0050775 |
positive regulation of dendrite morphogenesis(GO:0050775) |
| 5.7 |
17.2 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 5.7 |
34.3 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 5.7 |
5.7 |
GO:0042560 |
folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 5.7 |
17.1 |
GO:0034226 |
lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 5.7 |
34.2 |
GO:0072262 |
metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 5.7 |
28.3 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 5.6 |
39.5 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 5.6 |
16.9 |
GO:1904430 |
negative regulation of t-circle formation(GO:1904430) |
| 5.6 |
22.5 |
GO:2001153 |
regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 5.6 |
16.8 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 5.6 |
44.6 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 5.6 |
27.8 |
GO:0001766 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 5.5 |
5.5 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 5.5 |
43.6 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 5.4 |
5.4 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 5.4 |
21.6 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 5.4 |
16.2 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 5.4 |
21.5 |
GO:0035625 |
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 5.4 |
21.5 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 5.4 |
91.2 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 5.3 |
5.3 |
GO:0010661 |
positive regulation of muscle cell apoptotic process(GO:0010661) |
| 5.3 |
16.0 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 5.3 |
42.4 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 5.2 |
26.1 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 5.2 |
10.3 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 5.1 |
15.4 |
GO:1900169 |
regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 5.1 |
15.4 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 5.1 |
30.8 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 5.1 |
10.2 |
GO:0002884 |
negative regulation of hypersensitivity(GO:0002884) |
| 5.1 |
35.8 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 5.0 |
15.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 5.0 |
10.1 |
GO:0050720 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) interleukin-1 beta biosynthetic process(GO:0050720) |
| 5.0 |
5.0 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 5.0 |
5.0 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 5.0 |
15.0 |
GO:1902809 |
skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 4.9 |
34.6 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 4.9 |
14.7 |
GO:1905167 |
positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 4.9 |
14.7 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 4.9 |
29.2 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 4.9 |
14.6 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 4.9 |
38.8 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 4.8 |
14.5 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 4.8 |
19.3 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) |
| 4.8 |
38.2 |
GO:1903142 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 4.7 |
14.2 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 4.7 |
23.6 |
GO:1901339 |
regulation of store-operated calcium channel activity(GO:1901339) |
| 4.7 |
14.1 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 4.7 |
14.0 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 4.7 |
14.0 |
GO:0071810 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 4.6 |
13.9 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 4.6 |
4.6 |
GO:0015819 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
| 4.6 |
27.6 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 4.6 |
13.8 |
GO:0001172 |
transcription, RNA-templated(GO:0001172) |
| 4.6 |
36.7 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 4.6 |
50.2 |
GO:0000050 |
urea cycle(GO:0000050) |
| 4.6 |
4.6 |
GO:0021988 |
olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
| 4.6 |
27.4 |
GO:0036166 |
phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 4.6 |
22.8 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) |
| 4.5 |
9.1 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 4.5 |
9.1 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 4.5 |
31.8 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 4.5 |
13.6 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 4.5 |
18.1 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 4.5 |
4.5 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 4.5 |
4.5 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 4.5 |
31.6 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 4.5 |
45.1 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 4.5 |
18.0 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 4.5 |
45.0 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 4.5 |
4.5 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 4.5 |
4.5 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 4.5 |
31.4 |
GO:0072364 |
regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
| 4.5 |
13.4 |
GO:0060151 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 4.5 |
13.4 |
GO:0071321 |
cellular response to cGMP(GO:0071321) |
| 4.5 |
8.9 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 4.4 |
4.4 |
GO:1903960 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
| 4.4 |
13.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 4.4 |
4.4 |
GO:0060008 |
Sertoli cell differentiation(GO:0060008) |
| 4.4 |
39.4 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 4.4 |
26.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 4.4 |
13.1 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 4.3 |
17.4 |
GO:0045453 |
bone resorption(GO:0045453) |
| 4.3 |
17.3 |
GO:0019086 |
carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) late viral transcription(GO:0019086) |
| 4.3 |
13.0 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 4.3 |
8.6 |
GO:0003241 |
growth involved in heart morphogenesis(GO:0003241) |
| 4.3 |
12.9 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 4.3 |
25.8 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 4.3 |
12.8 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 4.3 |
21.3 |
GO:1901910 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 4.2 |
12.7 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 4.2 |
8.4 |
GO:0033602 |
negative regulation of dopamine secretion(GO:0033602) |
| 4.2 |
16.8 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 4.2 |
16.7 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 4.2 |
8.3 |
GO:1902723 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 4.1 |
20.7 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 4.1 |
4.1 |
GO:0048706 |
embryonic skeletal system development(GO:0048706) |
| 4.1 |
8.3 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 4.1 |
69.7 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 4.1 |
8.2 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 4.1 |
12.3 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 4.1 |
8.2 |
GO:0035723 |
interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 4.1 |
4.1 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 4.1 |
4.1 |
GO:0043634 |
polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 4.1 |
36.5 |
GO:0097647 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 4.0 |
28.3 |
GO:0032097 |
positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 4.0 |
12.1 |
GO:1901899 |
positive regulation of relaxation of cardiac muscle(GO:1901899) |
| 4.0 |
12.1 |
GO:0030311 |
poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 4.0 |
28.0 |
GO:0051480 |
regulation of cytosolic calcium ion concentration(GO:0051480) |
| 4.0 |
12.0 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 4.0 |
12.0 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 4.0 |
11.9 |
GO:2000870 |
regulation of progesterone secretion(GO:2000870) |
| 4.0 |
4.0 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 4.0 |
7.9 |
GO:0070781 |
response to biotin(GO:0070781) |
| 3.9 |
11.8 |
GO:0046066 |
dGDP metabolic process(GO:0046066) |
| 3.9 |
11.8 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 3.9 |
23.6 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 3.9 |
15.7 |
GO:2000343 |
positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
| 3.9 |
11.8 |
GO:0003358 |
noradrenergic neuron development(GO:0003358) |
| 3.9 |
11.8 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 3.9 |
15.7 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 3.9 |
50.6 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 3.9 |
34.7 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 3.8 |
19.2 |
GO:0031959 |
mineralocorticoid receptor signaling pathway(GO:0031959) |
| 3.8 |
49.6 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 3.8 |
76.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 3.8 |
11.4 |
GO:1902530 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 3.8 |
11.4 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 3.8 |
11.3 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 3.8 |
26.3 |
GO:0021999 |
neural plate anterior/posterior regionalization(GO:0021999) |
| 3.7 |
15.0 |
GO:0021633 |
optic nerve structural organization(GO:0021633) |
| 3.7 |
7.5 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 3.7 |
33.6 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 3.7 |
11.2 |
GO:0035963 |
cellular response to interleukin-13(GO:0035963) |
| 3.7 |
11.1 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 3.7 |
11.1 |
GO:0002625 |
regulation of T cell antigen processing and presentation(GO:0002625) |
| 3.7 |
7.4 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 3.7 |
25.8 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 3.7 |
11.0 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 3.7 |
3.7 |
GO:0060314 |
regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 3.7 |
7.3 |
GO:0043124 |
negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 3.6 |
3.6 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 3.6 |
21.8 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 3.6 |
10.9 |
GO:0061535 |
gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) glutamate secretion, neurotransmission(GO:0061535) |
| 3.6 |
3.6 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 3.6 |
14.5 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 3.6 |
10.9 |
GO:2001166 |
regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 3.6 |
14.5 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 3.6 |
10.8 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 3.6 |
3.6 |
GO:0044467 |
glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
| 3.6 |
10.7 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 3.6 |
17.9 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 3.6 |
14.3 |
GO:0034959 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 3.6 |
32.1 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 3.5 |
14.2 |
GO:0002238 |
response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 3.5 |
10.6 |
GO:1901731 |
positive regulation of platelet aggregation(GO:1901731) |
| 3.5 |
14.2 |
GO:0045409 |
negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 3.5 |
3.5 |
GO:0042327 |
positive regulation of phosphorylation(GO:0042327) |
| 3.5 |
10.6 |
GO:0042700 |
luteinizing hormone signaling pathway(GO:0042700) |
| 3.5 |
56.0 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 3.5 |
3.5 |
GO:0046824 |
positive regulation of nucleocytoplasmic transport(GO:0046824) |
| 3.5 |
10.5 |
GO:0009581 |
detection of external stimulus(GO:0009581) |
| 3.5 |
20.9 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 3.5 |
7.0 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 3.5 |
3.5 |
GO:1903514 |
calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
| 3.5 |
10.4 |
GO:0090034 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 3.5 |
3.5 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 3.5 |
6.9 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 3.4 |
6.9 |
GO:0031960 |
response to corticosteroid(GO:0031960) |
| 3.4 |
3.4 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 3.4 |
6.9 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) |
| 3.4 |
13.8 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 3.4 |
13.7 |
GO:0001826 |
inner cell mass cell differentiation(GO:0001826) |
| 3.4 |
13.6 |
GO:0042335 |
cuticle development(GO:0042335) |
| 3.4 |
23.9 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 3.4 |
27.2 |
GO:0009755 |
hormone-mediated signaling pathway(GO:0009755) steroid hormone mediated signaling pathway(GO:0043401) |
| 3.4 |
44.2 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 3.4 |
81.5 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 3.4 |
27.1 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 3.4 |
3.4 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 3.4 |
10.2 |
GO:0035284 |
rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 3.4 |
10.2 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 3.4 |
40.6 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 3.4 |
6.7 |
GO:0072237 |
metanephric proximal tubule development(GO:0072237) |
| 3.4 |
10.1 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 3.3 |
3.3 |
GO:1990641 |
response to iron ion starvation(GO:1990641) |
| 3.3 |
16.7 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 3.3 |
9.9 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 3.3 |
3.3 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 3.3 |
3.3 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 3.3 |
32.8 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 3.3 |
13.1 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 3.3 |
45.7 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 3.3 |
3.3 |
GO:0090521 |
glomerular visceral epithelial cell migration(GO:0090521) |
| 3.3 |
29.4 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 3.3 |
19.6 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 3.2 |
38.9 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 3.2 |
16.2 |
GO:2000639 |
regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 3.2 |
25.8 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 3.2 |
6.4 |
GO:0060061 |
Spemann organizer formation(GO:0060061) |
| 3.2 |
3.2 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 3.2 |
3.2 |
GO:0009794 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 3.2 |
9.6 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 3.2 |
3.2 |
GO:0003218 |
cardiac left ventricle formation(GO:0003218) |
| 3.2 |
41.5 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 3.2 |
3.2 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 3.2 |
3.2 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 3.2 |
12.7 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 3.2 |
19.0 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 3.2 |
3.2 |
GO:0010212 |
response to ionizing radiation(GO:0010212) |
| 3.1 |
21.9 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 3.1 |
25.0 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 3.1 |
6.2 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 3.1 |
3.1 |
GO:0046545 |
development of primary female sexual characteristics(GO:0046545) female sex differentiation(GO:0046660) |
| 3.1 |
9.2 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 3.1 |
15.3 |
GO:0099538 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 3.1 |
15.3 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 3.0 |
15.2 |
GO:0030070 |
insulin processing(GO:0030070) |
| 3.0 |
6.1 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 3.0 |
202.2 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 3.0 |
21.1 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 3.0 |
6.0 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 3.0 |
51.0 |
GO:0002230 |
positive regulation of defense response to virus by host(GO:0002230) |
| 3.0 |
12.0 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 3.0 |
3.0 |
GO:1900076 |
regulation of cellular response to insulin stimulus(GO:1900076) |
| 3.0 |
3.0 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 3.0 |
20.8 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 3.0 |
3.0 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) negative regulation of hippo signaling(GO:0035331) |
| 3.0 |
5.9 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 3.0 |
14.8 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 2.9 |
17.6 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 2.9 |
23.5 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 2.9 |
11.7 |
GO:0009730 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 2.9 |
23.3 |
GO:1901525 |
negative regulation of macromitophagy(GO:1901525) |
| 2.9 |
11.6 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 2.9 |
2.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 2.9 |
8.7 |
GO:2000824 |
negative regulation of androgen receptor activity(GO:2000824) |
| 2.9 |
11.5 |
GO:0051122 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 2.9 |
8.6 |
GO:0002522 |
leukocyte migration involved in immune response(GO:0002522) |
| 2.9 |
43.0 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 2.9 |
5.7 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 2.9 |
100.0 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
| 2.9 |
14.3 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 2.9 |
20.0 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 2.8 |
14.2 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 2.8 |
11.4 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 2.8 |
8.5 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 2.8 |
14.2 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 2.8 |
45.3 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 2.8 |
11.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 2.8 |
31.0 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 2.8 |
8.5 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 2.8 |
8.4 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 2.8 |
5.6 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 2.8 |
8.4 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 2.8 |
8.4 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 2.8 |
2.8 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 2.8 |
13.8 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 2.8 |
5.5 |
GO:0051231 |
spindle elongation(GO:0051231) |
| 2.7 |
11.0 |
GO:0048505 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 2.7 |
8.2 |
GO:0033504 |
floor plate development(GO:0033504) |
| 2.7 |
16.3 |
GO:2000834 |
androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 2.7 |
5.4 |
GO:0035264 |
multicellular organism growth(GO:0035264) |
| 2.7 |
21.6 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) |
| 2.7 |
27.0 |
GO:0050942 |
positive regulation of pigment cell differentiation(GO:0050942) |
| 2.7 |
2.7 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 2.7 |
8.1 |
GO:1990737 |
response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 2.7 |
10.7 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 2.7 |
10.7 |
GO:0072007 |
mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) |
| 2.7 |
40.0 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 2.7 |
8.0 |
GO:0002276 |
basophil activation involved in immune response(GO:0002276) |
| 2.7 |
10.6 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 2.7 |
10.6 |
GO:2000671 |
regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
| 2.6 |
7.9 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 2.6 |
5.3 |
GO:0071315 |
cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 2.6 |
18.5 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 2.6 |
31.6 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 2.6 |
18.3 |
GO:0045007 |
depurination(GO:0045007) |
| 2.6 |
15.7 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 2.6 |
2.6 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 2.6 |
96.3 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 2.6 |
31.2 |
GO:1903859 |
regulation of dendrite extension(GO:1903859) |
| 2.6 |
5.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 2.6 |
38.9 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 2.6 |
2.6 |
GO:2000584 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 2.6 |
10.3 |
GO:0061743 |
motor learning(GO:0061743) |
| 2.6 |
5.1 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 2.6 |
7.7 |
GO:0072248 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 2.6 |
28.2 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 2.6 |
5.1 |
GO:0001101 |
response to acid chemical(GO:0001101) |
| 2.6 |
20.5 |
GO:0007506 |
gonadal mesoderm development(GO:0007506) |
| 2.6 |
10.2 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 2.6 |
2.6 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 2.6 |
17.9 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 2.6 |
5.1 |
GO:0034444 |
regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 2.5 |
56.1 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 2.5 |
7.6 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 2.5 |
50.4 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) |
| 2.5 |
5.0 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 2.5 |
2.5 |
GO:0035802 |
adrenal cortex development(GO:0035801) adrenal cortex formation(GO:0035802) |
| 2.5 |
12.4 |
GO:0070945 |
neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 2.5 |
5.0 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 2.5 |
7.4 |
GO:1904306 |
regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
| 2.5 |
2.5 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 2.5 |
4.9 |
GO:1904204 |
regulation of skeletal muscle hypertrophy(GO:1904204) |
| 2.5 |
2.5 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 2.5 |
2.5 |
GO:0032416 |
negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 2.5 |
12.3 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 2.5 |
17.2 |
GO:0097012 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 2.4 |
7.3 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 2.4 |
26.9 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 2.4 |
7.3 |
GO:0010659 |
cardiac muscle cell apoptotic process(GO:0010659) |
| 2.4 |
2.4 |
GO:0035357 |
peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
| 2.4 |
9.7 |
GO:0072240 |
DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 2.4 |
2.4 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 2.4 |
14.5 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 2.4 |
2.4 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 2.4 |
16.9 |
GO:0015705 |
iodide transport(GO:0015705) |
| 2.4 |
12.0 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 2.4 |
4.8 |
GO:1904502 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 2.4 |
4.8 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 2.4 |
2.4 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 2.4 |
11.9 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 2.4 |
9.5 |
GO:0097113 |
AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 2.4 |
11.8 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 2.4 |
7.1 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 2.4 |
4.7 |
GO:2000410 |
regulation of thymocyte migration(GO:2000410) |
| 2.4 |
9.4 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 2.3 |
49.2 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 2.3 |
7.0 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 2.3 |
2.3 |
GO:0086015 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 2.3 |
23.3 |
GO:0036155 |
acylglycerol acyl-chain remodeling(GO:0036155) |
| 2.3 |
9.3 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 2.3 |
2.3 |
GO:0042461 |
photoreceptor cell development(GO:0042461) |
| 2.3 |
2.3 |
GO:0019367 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 2.3 |
11.6 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 2.3 |
23.1 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 2.3 |
11.5 |
GO:1904100 |
regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 2.3 |
34.6 |
GO:0006751 |
glutathione catabolic process(GO:0006751) |
| 2.3 |
18.4 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 2.3 |
13.8 |
GO:0090042 |
tubulin deacetylation(GO:0090042) |
| 2.3 |
4.6 |
GO:0034653 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 2.3 |
2.3 |
GO:0021650 |
vestibulocochlear nerve formation(GO:0021650) |
| 2.3 |
4.6 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 2.3 |
2.3 |
GO:0032715 |
negative regulation of interleukin-6 production(GO:0032715) |
| 2.3 |
20.6 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 2.3 |
6.9 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 2.3 |
2.3 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 2.3 |
6.8 |
GO:0002042 |
cell migration involved in sprouting angiogenesis(GO:0002042) |
| 2.3 |
9.1 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 2.3 |
70.4 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 2.3 |
4.5 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 2.3 |
20.4 |
GO:0051410 |
detoxification of nitrogen compound(GO:0051410) |
| 2.3 |
90.1 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 2.2 |
24.7 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 2.2 |
47.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 2.2 |
6.7 |
GO:0060452 |
positive regulation of cardiac muscle contraction(GO:0060452) |
| 2.2 |
2.2 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 2.2 |
13.3 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 2.2 |
11.1 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 2.2 |
30.9 |
GO:0098719 |
sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 2.2 |
4.4 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 2.2 |
6.6 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 2.2 |
4.4 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 2.2 |
32.9 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 2.2 |
6.6 |
GO:0046618 |
drug export(GO:0046618) |
| 2.2 |
19.7 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 2.2 |
8.8 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 2.2 |
8.7 |
GO:0071027 |
nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 2.2 |
8.7 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 2.2 |
56.6 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 2.2 |
4.4 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 2.2 |
6.5 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 2.2 |
13.0 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 2.2 |
13.0 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 2.2 |
8.7 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 2.2 |
6.5 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 2.2 |
8.6 |
GO:0006203 |
dGTP catabolic process(GO:0006203) |
| 2.2 |
28.0 |
GO:0001976 |
neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 2.2 |
19.4 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 2.1 |
8.6 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 2.1 |
42.9 |
GO:0006853 |
carnitine shuttle(GO:0006853) |
| 2.1 |
6.4 |
GO:0043006 |
activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 2.1 |
19.3 |
GO:0015747 |
urate transport(GO:0015747) |
| 2.1 |
2.1 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 2.1 |
2.1 |
GO:0002554 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 2.1 |
23.4 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 2.1 |
12.8 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 2.1 |
21.3 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 2.1 |
2.1 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 2.1 |
4.2 |
GO:0086067 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) AV node cell to bundle of His cell communication(GO:0086067) |
| 2.1 |
27.6 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 2.1 |
12.7 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 2.1 |
2.1 |
GO:0072038 |
mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
| 2.1 |
6.4 |
GO:0072567 |
chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
| 2.1 |
2.1 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 2.1 |
6.3 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 2.1 |
19.0 |
GO:0090037 |
positive regulation of protein kinase C signaling(GO:0090037) |
| 2.1 |
8.4 |
GO:0051612 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 2.1 |
6.3 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 2.1 |
23.1 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 2.1 |
6.3 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 2.1 |
4.2 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 2.1 |
10.5 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 2.1 |
2.1 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 2.1 |
6.2 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 2.1 |
2.1 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 2.1 |
16.6 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 2.1 |
8.3 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 2.1 |
14.5 |
GO:0043647 |
inositol phosphate metabolic process(GO:0043647) |
| 2.1 |
30.8 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 2.1 |
8.2 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 2.0 |
12.3 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 2.0 |
4.1 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 2.0 |
18.4 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 2.0 |
4.1 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 2.0 |
6.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 2.0 |
6.1 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 2.0 |
12.2 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 2.0 |
10.1 |
GO:0009597 |
detection of virus(GO:0009597) |
| 2.0 |
38.6 |
GO:0045332 |
lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 2.0 |
20.2 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 2.0 |
10.1 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 2.0 |
8.1 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 2.0 |
10.1 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 2.0 |
10.1 |
GO:0032377 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 2.0 |
6.0 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 2.0 |
8.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 2.0 |
6.0 |
GO:0061744 |
motor behavior(GO:0061744) |
| 2.0 |
2.0 |
GO:1904379 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 2.0 |
6.0 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 2.0 |
10.0 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 2.0 |
2.0 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 2.0 |
4.0 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 2.0 |
2.0 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 2.0 |
9.9 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 2.0 |
11.9 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 2.0 |
2.0 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 2.0 |
4.0 |
GO:0099624 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 2.0 |
4.0 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 2.0 |
5.9 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 2.0 |
5.9 |
GO:1901053 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 2.0 |
11.8 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 2.0 |
3.9 |
GO:0021860 |
pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 2.0 |
3.9 |
GO:0021938 |
ventral midline development(GO:0007418) cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 2.0 |
9.8 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 2.0 |
9.8 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 1.9 |
3.9 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 1.9 |
3.9 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 1.9 |
1.9 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 1.9 |
3.9 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 1.9 |
3.9 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 1.9 |
3.9 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 1.9 |
1.9 |
GO:0061549 |
sympathetic ganglion development(GO:0061549) |
| 1.9 |
11.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 1.9 |
7.7 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 1.9 |
19.2 |
GO:1901678 |
heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
| 1.9 |
1.9 |
GO:0032388 |
positive regulation of intracellular transport(GO:0032388) |
| 1.9 |
11.5 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 1.9 |
5.7 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 1.9 |
1.9 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.9 |
9.5 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 1.9 |
1.9 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 1.9 |
5.7 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 1.9 |
5.7 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 1.9 |
13.2 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 1.9 |
5.7 |
GO:1901727 |
positive regulation of deacetylase activity(GO:0090045) positive regulation of histone deacetylase activity(GO:1901727) |
| 1.9 |
9.4 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 1.9 |
1.9 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.9 |
11.2 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 1.9 |
1.9 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 1.9 |
9.3 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 1.9 |
5.6 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 1.9 |
3.7 |
GO:1902548 |
negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 1.8 |
7.4 |
GO:0051255 |
spindle midzone assembly(GO:0051255) |
| 1.8 |
7.4 |
GO:0002088 |
lens development in camera-type eye(GO:0002088) |
| 1.8 |
11.0 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 1.8 |
5.5 |
GO:0010615 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.8 |
3.7 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 1.8 |
29.1 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 1.8 |
3.6 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 1.8 |
5.5 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 1.8 |
18.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 1.8 |
3.6 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 1.8 |
7.2 |
GO:0021546 |
rhombomere development(GO:0021546) |
| 1.8 |
5.4 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 1.8 |
5.4 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 1.8 |
19.7 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 1.8 |
12.6 |
GO:0021924 |
cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 1.8 |
80.7 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 1.8 |
5.4 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 1.8 |
3.6 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 1.8 |
1.8 |
GO:2001054 |
negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 1.8 |
8.9 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 1.8 |
12.5 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 1.8 |
1.8 |
GO:1903626 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 1.8 |
19.5 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 1.8 |
10.6 |
GO:0060051 |
negative regulation of protein ADP-ribosylation(GO:0010836) negative regulation of protein glycosylation(GO:0060051) |
| 1.8 |
14.1 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 1.8 |
5.3 |
GO:0006875 |
cellular metal ion homeostasis(GO:0006875) |
| 1.8 |
1.8 |
GO:0018153 |
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 1.7 |
5.2 |
GO:0035524 |
proline transmembrane transport(GO:0035524) |
| 1.7 |
5.2 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 1.7 |
48.5 |
GO:0072378 |
blood coagulation, fibrin clot formation(GO:0072378) |
| 1.7 |
6.9 |
GO:0009137 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.7 |
10.3 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.7 |
5.1 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 1.7 |
11.9 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 1.7 |
1.7 |
GO:0060349 |
bone morphogenesis(GO:0060349) |
| 1.7 |
25.4 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 1.7 |
3.4 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 1.7 |
3.4 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 1.7 |
5.0 |
GO:0005988 |
lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 1.7 |
6.7 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 1.7 |
8.4 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 1.7 |
13.4 |
GO:0021794 |
thalamus development(GO:0021794) |
| 1.7 |
6.7 |
GO:2000318 |
T-helper 2 cell activation(GO:0035712) positive regulation of T-helper 17 type immune response(GO:2000318) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 1.7 |
11.7 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 1.7 |
1.7 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 1.7 |
10.0 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 1.7 |
3.3 |
GO:0060711 |
labyrinthine layer development(GO:0060711) |
| 1.7 |
6.7 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 1.7 |
16.6 |
GO:0006983 |
ER overload response(GO:0006983) |
| 1.7 |
11.6 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 1.7 |
21.6 |
GO:0007512 |
adult heart development(GO:0007512) |
| 1.7 |
5.0 |
GO:1904640 |
response to methionine(GO:1904640) |
| 1.7 |
21.5 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 1.7 |
8.3 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 1.6 |
18.1 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 1.6 |
3.3 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 1.6 |
4.9 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 1.6 |
4.9 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.6 |
14.8 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 1.6 |
3.3 |
GO:0097107 |
postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 1.6 |
6.6 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 1.6 |
4.9 |
GO:0001694 |
histamine biosynthetic process(GO:0001694) |
| 1.6 |
3.3 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 1.6 |
6.5 |
GO:0045906 |
negative regulation of vasoconstriction(GO:0045906) |
| 1.6 |
3.3 |
GO:0014054 |
positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 1.6 |
1.6 |
GO:0032304 |
negative regulation of icosanoid secretion(GO:0032304) |
| 1.6 |
4.9 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 1.6 |
11.4 |
GO:2000828 |
post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 1.6 |
4.9 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 1.6 |
8.1 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 1.6 |
12.9 |
GO:0002438 |
acute inflammatory response to antigenic stimulus(GO:0002438) |
| 1.6 |
9.6 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 1.6 |
16.0 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 1.6 |
3.2 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 1.6 |
12.8 |
GO:0010935 |
regulation of macrophage cytokine production(GO:0010935) |
| 1.6 |
17.5 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 1.6 |
1.6 |
GO:0003307 |
regulation of Wnt signaling pathway involved in heart development(GO:0003307) |
| 1.6 |
7.9 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 1.6 |
39.2 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 1.6 |
7.8 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 1.6 |
48.5 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 1.6 |
4.7 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 1.6 |
3.1 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 1.6 |
3.1 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 1.6 |
3.1 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 1.6 |
3.1 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 1.6 |
9.3 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 1.5 |
15.4 |
GO:0051567 |
histone H3-K9 methylation(GO:0051567) |
| 1.5 |
7.7 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 1.5 |
6.1 |
GO:0010863 |
positive regulation of phospholipase C activity(GO:0010863) |
| 1.5 |
7.7 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 1.5 |
1.5 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 1.5 |
4.6 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 1.5 |
7.6 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 1.5 |
21.3 |
GO:1904152 |
regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 1.5 |
3.0 |
GO:0050804 |
modulation of synaptic transmission(GO:0050804) |
| 1.5 |
35.0 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 1.5 |
4.5 |
GO:2000538 |
regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 1.5 |
3.0 |
GO:0042752 |
regulation of circadian rhythm(GO:0042752) |
| 1.5 |
4.5 |
GO:0033029 |
neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 1.5 |
36.0 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 1.5 |
15.0 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 1.5 |
9.0 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 1.5 |
3.0 |
GO:0045199 |
maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 1.5 |
3.0 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 1.5 |
7.5 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 1.5 |
1.5 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 1.5 |
38.5 |
GO:0097503 |
sialylation(GO:0097503) |
| 1.5 |
16.3 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 1.5 |
4.4 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 1.5 |
5.9 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 1.5 |
4.4 |
GO:0072384 |
organelle transport along microtubule(GO:0072384) |
| 1.5 |
1.5 |
GO:0060563 |
neuroepithelial cell differentiation(GO:0060563) |
| 1.5 |
2.9 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 1.4 |
26.1 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 1.4 |
11.5 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 1.4 |
21.6 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 1.4 |
1.4 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 1.4 |
5.7 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) |
| 1.4 |
1.4 |
GO:0071286 |
cellular response to magnesium ion(GO:0071286) |
| 1.4 |
5.7 |
GO:0070091 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 1.4 |
1.4 |
GO:0060544 |
regulation of necroptotic process(GO:0060544) |
| 1.4 |
1.4 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 1.4 |
11.4 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 1.4 |
7.1 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 1.4 |
5.7 |
GO:0070444 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.4 |
4.2 |
GO:0045626 |
negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 1.4 |
4.2 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 1.4 |
36.6 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 1.4 |
13.9 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 1.4 |
9.7 |
GO:0048104 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.4 |
2.8 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 1.4 |
5.5 |
GO:0046514 |
glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) ceramide catabolic process(GO:0046514) |
| 1.4 |
2.8 |
GO:0021831 |
embryonic olfactory bulb interneuron precursor migration(GO:0021831) chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
| 1.4 |
4.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 1.4 |
4.1 |
GO:0019448 |
cysteine biosynthetic process from serine(GO:0006535) cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 1.4 |
5.5 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 1.4 |
1.4 |
GO:2000191 |
regulation of fatty acid transport(GO:2000191) |
| 1.4 |
6.9 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 1.4 |
2.7 |
GO:0071673 |
positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 1.4 |
2.7 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 1.4 |
19.1 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 1.4 |
10.8 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 1.4 |
10.8 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 1.4 |
6.8 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 1.3 |
20.2 |
GO:0043981 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 1.3 |
1.3 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 1.3 |
8.0 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 1.3 |
8.0 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 1.3 |
17.3 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 1.3 |
1.3 |
GO:0014075 |
response to amine(GO:0014075) |
| 1.3 |
45.1 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 1.3 |
11.8 |
GO:0044117 |
growth of symbiont in host(GO:0044117) |
| 1.3 |
1.3 |
GO:0031646 |
positive regulation of neurological system process(GO:0031646) |
| 1.3 |
9.2 |
GO:0051496 |
positive regulation of stress fiber assembly(GO:0051496) |
| 1.3 |
2.6 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.3 |
2.6 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 1.3 |
1.3 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 1.3 |
6.5 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 1.3 |
1.3 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 1.3 |
1.3 |
GO:0003160 |
endocardium morphogenesis(GO:0003160) |
| 1.3 |
3.9 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 1.3 |
3.9 |
GO:0090009 |
primitive streak formation(GO:0090009) |
| 1.3 |
3.9 |
GO:1905203 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) regulation of connective tissue replacement(GO:1905203) negative regulation of connective tissue replacement(GO:1905204) |
| 1.3 |
2.6 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 1.3 |
1.3 |
GO:0060599 |
lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 1.3 |
6.5 |
GO:1900920 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 1.3 |
2.6 |
GO:1900154 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 1.3 |
25.8 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 1.3 |
3.9 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 1.3 |
2.6 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 1.3 |
1.3 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 1.3 |
9.0 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 1.3 |
20.5 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 1.3 |
7.7 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 1.3 |
6.4 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 1.3 |
29.3 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 1.3 |
2.5 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 1.3 |
8.9 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 1.3 |
15.2 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 1.3 |
3.8 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 1.3 |
6.3 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 1.3 |
3.8 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 1.3 |
3.8 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 1.3 |
10.0 |
GO:0072401 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 1.3 |
2.5 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 1.2 |
23.7 |
GO:0007616 |
long-term memory(GO:0007616) |
| 1.2 |
11.2 |
GO:2000291 |
myoblast proliferation(GO:0051450) regulation of myoblast proliferation(GO:2000291) |
| 1.2 |
5.0 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 1.2 |
7.5 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 1.2 |
5.0 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 1.2 |
3.7 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 1.2 |
2.5 |
GO:0002865 |
negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 1.2 |
6.2 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 1.2 |
9.9 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 1.2 |
4.9 |
GO:0042426 |
choline catabolic process(GO:0042426) |
| 1.2 |
9.9 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 1.2 |
7.4 |
GO:0036005 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 1.2 |
4.9 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 1.2 |
20.8 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 1.2 |
4.9 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 1.2 |
7.3 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 1.2 |
9.8 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.2 |
6.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 1.2 |
2.4 |
GO:0034441 |
plasma lipoprotein particle oxidation(GO:0034441) |
| 1.2 |
4.8 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 1.2 |
7.3 |
GO:0030421 |
defecation(GO:0030421) |
| 1.2 |
2.4 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 1.2 |
7.3 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 1.2 |
9.6 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 1.2 |
15.6 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 1.2 |
2.4 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 1.2 |
2.4 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 1.2 |
2.4 |
GO:0045631 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.2 |
2.4 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 1.2 |
14.2 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 1.2 |
1.2 |
GO:0045161 |
neuronal ion channel clustering(GO:0045161) |
| 1.2 |
1.2 |
GO:0061218 |
negative regulation of mesonephros development(GO:0061218) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 1.2 |
4.7 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 1.2 |
10.5 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 1.2 |
4.7 |
GO:0031443 |
fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 1.2 |
1.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 1.2 |
3.5 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 1.2 |
17.4 |
GO:0046135 |
pyrimidine nucleoside catabolic process(GO:0046135) |
| 1.2 |
3.5 |
GO:0043105 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 1.2 |
2.3 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 1.1 |
2.3 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.1 |
3.4 |
GO:0042148 |
strand invasion(GO:0042148) |
| 1.1 |
5.7 |
GO:1901160 |
primary amino compound metabolic process(GO:1901160) |
| 1.1 |
2.3 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 1.1 |
5.7 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 1.1 |
5.7 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 1.1 |
22.8 |
GO:0048935 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 1.1 |
18.2 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 1.1 |
4.5 |
GO:1903564 |
regulation of protein localization to cilium(GO:1903564) |
| 1.1 |
9.1 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 1.1 |
9.1 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 1.1 |
2.3 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 1.1 |
29.5 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 1.1 |
14.7 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 1.1 |
9.0 |
GO:0060037 |
pharyngeal system development(GO:0060037) |
| 1.1 |
18.0 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 1.1 |
2.2 |
GO:1903358 |
regulation of Golgi organization(GO:1903358) |
| 1.1 |
4.5 |
GO:2000463 |
positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 1.1 |
7.8 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 1.1 |
5.6 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 1.1 |
4.5 |
GO:0060605 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 1.1 |
3.3 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 1.1 |
3.3 |
GO:0042701 |
progesterone secretion(GO:0042701) |
| 1.1 |
6.6 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 1.1 |
6.6 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 1.1 |
5.5 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 1.1 |
11.0 |
GO:0060022 |
hard palate development(GO:0060022) |
| 1.1 |
5.5 |
GO:2000400 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 1.1 |
3.3 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 1.1 |
7.7 |
GO:0030449 |
regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 1.1 |
10.9 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 1.1 |
1.1 |
GO:0051604 |
protein maturation(GO:0051604) |
| 1.1 |
16.3 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 1.1 |
3.2 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 1.1 |
3.2 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 1.1 |
3.2 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 1.1 |
3.2 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 1.1 |
5.4 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 1.1 |
3.2 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 1.1 |
4.3 |
GO:0036124 |
histone H3-K9 trimethylation(GO:0036124) |
| 1.1 |
1.1 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 1.1 |
5.3 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 1.1 |
8.5 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 1.1 |
18.1 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 1.1 |
8.5 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 1.1 |
9.6 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 1.1 |
8.5 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 1.1 |
4.2 |
GO:0006196 |
AMP catabolic process(GO:0006196) |
| 1.1 |
3.2 |
GO:0043606 |
histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 1.1 |
13.7 |
GO:0042711 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 1.1 |
1.1 |
GO:1902679 |
negative regulation of RNA biosynthetic process(GO:1902679) |
| 1.1 |
9.5 |
GO:0034312 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 1.1 |
4.2 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 1.0 |
11.5 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 1.0 |
7.3 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 1.0 |
12.5 |
GO:0030517 |
negative regulation of axon extension(GO:0030517) |
| 1.0 |
2.1 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 1.0 |
4.2 |
GO:0090288 |
negative regulation of cellular response to growth factor stimulus(GO:0090288) |
| 1.0 |
1.0 |
GO:0042559 |
folic acid-containing compound biosynthetic process(GO:0009396) pteridine-containing compound biosynthetic process(GO:0042559) |
| 1.0 |
12.4 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 1.0 |
4.1 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 1.0 |
8.3 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 1.0 |
2.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 1.0 |
7.2 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 1.0 |
6.1 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 1.0 |
3.1 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 1.0 |
2.0 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 1.0 |
2.0 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 1.0 |
2.0 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
| 1.0 |
15.2 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 1.0 |
2.0 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.0 |
4.1 |
GO:0009822 |
alkaloid catabolic process(GO:0009822) |
| 1.0 |
2.0 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 1.0 |
3.0 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 1.0 |
4.0 |
GO:2000169 |
regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 1.0 |
11.0 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 1.0 |
2.0 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 1.0 |
5.0 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 1.0 |
4.0 |
GO:0007320 |
insemination(GO:0007320) |
| 1.0 |
8.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 1.0 |
3.0 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 1.0 |
9.0 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 1.0 |
2.0 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 1.0 |
3.0 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 1.0 |
19.7 |
GO:0035773 |
insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
| 1.0 |
2.0 |
GO:0042982 |
amyloid precursor protein metabolic process(GO:0042982) |
| 1.0 |
2.0 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 1.0 |
9.8 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 1.0 |
3.9 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 1.0 |
3.9 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 1.0 |
8.8 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 1.0 |
5.8 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 1.0 |
1.0 |
GO:0022616 |
DNA strand elongation involved in DNA replication(GO:0006271) DNA strand elongation(GO:0022616) |
| 1.0 |
1.9 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 1.0 |
1.9 |
GO:0071504 |
response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 1.0 |
7.7 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 1.0 |
5.8 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 1.0 |
6.7 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 1.0 |
2.9 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 1.0 |
10.5 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.9 |
1.9 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.9 |
3.8 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.9 |
9.4 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.9 |
14.1 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.9 |
0.9 |
GO:0060579 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.9 |
8.5 |
GO:1990035 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.9 |
0.9 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.9 |
9.4 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.9 |
6.5 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.9 |
2.8 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.9 |
12.1 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.9 |
38.8 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.9 |
8.3 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.9 |
23.9 |
GO:0043268 |
positive regulation of potassium ion transport(GO:0043268) |
| 0.9 |
1.8 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.9 |
45.7 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.9 |
29.2 |
GO:0007189 |
adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.9 |
11.8 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.9 |
2.7 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.9 |
4.5 |
GO:0061647 |
histone H3-K9 modification(GO:0061647) |
| 0.9 |
1.8 |
GO:0042984 |
amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.9 |
73.1 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.9 |
9.9 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.9 |
5.4 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.9 |
1.8 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.9 |
8.1 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.9 |
1.8 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.9 |
41.2 |
GO:0006584 |
catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.9 |
2.7 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.9 |
20.5 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.9 |
11.6 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.9 |
3.6 |
GO:0021895 |
cerebral cortex neuron differentiation(GO:0021895) |
| 0.9 |
8.9 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.9 |
2.7 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.9 |
2.6 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.9 |
2.6 |
GO:0042749 |
regulation of circadian sleep/wake cycle(GO:0042749) |
| 0.9 |
0.9 |
GO:1903020 |
positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.9 |
5.3 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.9 |
0.9 |
GO:0010840 |
regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.9 |
2.6 |
GO:0090196 |
chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
| 0.9 |
2.6 |
GO:1904970 |
intermicrovillar adhesion(GO:0090675) brush border assembly(GO:1904970) |
| 0.9 |
20.9 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.9 |
26.7 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.9 |
1.7 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.9 |
0.9 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.9 |
3.4 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.9 |
0.9 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.9 |
2.6 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.9 |
2.6 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.9 |
4.3 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.8 |
5.9 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.8 |
18.6 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.8 |
15.2 |
GO:0046676 |
negative regulation of peptide secretion(GO:0002792) negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
| 0.8 |
1.7 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.8 |
1.7 |
GO:0008595 |
tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.8 |
8.3 |
GO:0010663 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.8 |
6.6 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.8 |
5.0 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.8 |
1.7 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.8 |
5.0 |
GO:0021826 |
substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.8 |
3.3 |
GO:2000852 |
corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 0.8 |
6.6 |
GO:0006111 |
regulation of gluconeogenesis(GO:0006111) |
| 0.8 |
3.3 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.8 |
2.5 |
GO:0035564 |
regulation of kidney size(GO:0035564) regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) pronephros morphogenesis(GO:0072114) |
| 0.8 |
7.3 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.8 |
8.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.8 |
10.6 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 0.8 |
2.4 |
GO:0046440 |
L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.8 |
1.6 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.8 |
2.4 |
GO:0061536 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.8 |
2.4 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.8 |
4.0 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.8 |
8.8 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.8 |
8.0 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.8 |
1.6 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.8 |
3.2 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.8 |
6.4 |
GO:0009304 |
tRNA transcription(GO:0009304) |
| 0.8 |
3.1 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.8 |
2.3 |
GO:0070508 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.8 |
2.3 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.8 |
2.3 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.8 |
13.8 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.8 |
2.3 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.8 |
0.8 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.8 |
7.6 |
GO:0035909 |
aorta morphogenesis(GO:0035909) |
| 0.8 |
15.2 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.8 |
4.5 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.8 |
7.5 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.8 |
5.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.8 |
2.3 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.7 |
27.7 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.7 |
0.7 |
GO:0051788 |
response to misfolded protein(GO:0051788) |
| 0.7 |
3.0 |
GO:0002913 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.7 |
3.7 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.7 |
2.2 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.7 |
2.2 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.7 |
3.7 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.7 |
0.7 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.7 |
1.5 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
| 0.7 |
1.5 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.7 |
3.7 |
GO:0001825 |
blastocyst formation(GO:0001825) |
| 0.7 |
1.5 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.7 |
1.5 |
GO:0048664 |
neuron fate determination(GO:0048664) |
| 0.7 |
13.2 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.7 |
3.7 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.7 |
0.7 |
GO:0050932 |
regulation of pigment cell differentiation(GO:0050932) |
| 0.7 |
2.2 |
GO:0051932 |
synaptic transmission, GABAergic(GO:0051932) |
| 0.7 |
2.1 |
GO:0021544 |
subpallium development(GO:0021544) striatum development(GO:0021756) |
| 0.7 |
8.6 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.7 |
5.7 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.7 |
2.8 |
GO:0030048 |
actin filament-based movement(GO:0030048) |
| 0.7 |
9.1 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.7 |
4.9 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.7 |
2.1 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.7 |
13.9 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.7 |
4.1 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.7 |
46.9 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.7 |
1.4 |
GO:0098759 |
response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.7 |
4.1 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.7 |
4.8 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.7 |
0.7 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
| 0.7 |
2.1 |
GO:0050860 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.7 |
7.5 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.7 |
3.4 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.7 |
3.4 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.7 |
10.9 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) |
| 0.7 |
1.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.7 |
4.7 |
GO:0010800 |
positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.7 |
2.7 |
GO:0007635 |
chemosensory behavior(GO:0007635) |
| 0.7 |
40.3 |
GO:0018410 |
C-terminal protein amino acid modification(GO:0018410) |
| 0.7 |
0.7 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.7 |
9.4 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.7 |
1.3 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) cellular amide catabolic process(GO:0043605) |
| 0.7 |
1.3 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.7 |
0.7 |
GO:0007494 |
midgut development(GO:0007494) |
| 0.7 |
3.3 |
GO:1904672 |
regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.7 |
4.0 |
GO:0002760 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.7 |
0.7 |
GO:0009314 |
response to radiation(GO:0009314) |
| 0.7 |
1.3 |
GO:0060215 |
primitive hemopoiesis(GO:0060215) |
| 0.7 |
4.6 |
GO:0099500 |
synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.6 |
7.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.6 |
6.4 |
GO:0030202 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.6 |
3.2 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.6 |
1.9 |
GO:0060424 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) primary lung bud formation(GO:0060431) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 0.6 |
10.1 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.6 |
3.2 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.6 |
10.7 |
GO:0039694 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.6 |
5.0 |
GO:0042355 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.6 |
1.9 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.6 |
6.2 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 0.6 |
6.2 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.6 |
5.6 |
GO:1990416 |
cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.6 |
1.8 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.6 |
2.5 |
GO:0060384 |
innervation(GO:0060384) |
| 0.6 |
8.6 |
GO:2000050 |
regulation of non-canonical Wnt signaling pathway(GO:2000050) |
| 0.6 |
2.4 |
GO:0018195 |
peptidyl-arginine modification(GO:0018195) |
| 0.6 |
4.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.6 |
1.8 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.6 |
3.0 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.6 |
4.2 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.6 |
13.7 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.6 |
3.0 |
GO:0045657 |
positive regulation of monocyte differentiation(GO:0045657) |
| 0.6 |
1.2 |
GO:0032466 |
negative regulation of cytokinesis(GO:0032466) |
| 0.6 |
1.2 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.6 |
1.8 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.6 |
2.4 |
GO:0050926 |
regulation of positive chemotaxis(GO:0050926) positive regulation of positive chemotaxis(GO:0050927) |
| 0.6 |
42.4 |
GO:0010921 |
regulation of phosphatase activity(GO:0010921) |
| 0.6 |
4.1 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.6 |
2.9 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.6 |
0.6 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.6 |
2.3 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.6 |
2.9 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.6 |
1.7 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 |
2.3 |
GO:0046465 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.6 |
3.4 |
GO:0006531 |
aspartate metabolic process(GO:0006531) |
| 0.6 |
1.1 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.6 |
37.0 |
GO:0006813 |
potassium ion transport(GO:0006813) |
| 0.6 |
2.8 |
GO:1901563 |
response to camptothecin(GO:1901563) |
| 0.6 |
14.2 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.6 |
1.7 |
GO:0001554 |
luteolysis(GO:0001554) |
| 0.6 |
1.1 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.6 |
6.2 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.6 |
0.6 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.6 |
2.2 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.6 |
7.8 |
GO:0061337 |
cardiac conduction(GO:0061337) |
| 0.6 |
3.3 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.6 |
6.1 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.5 |
2.2 |
GO:0010623 |
programmed cell death involved in cell development(GO:0010623) |
| 0.5 |
3.3 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.5 |
0.5 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.5 |
1.6 |
GO:0002677 |
chronic inflammatory response to non-antigenic stimulus(GO:0002545) negative regulation of chronic inflammatory response(GO:0002677) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
| 0.5 |
6.5 |
GO:0050852 |
T cell receptor signaling pathway(GO:0050852) |
| 0.5 |
2.7 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.5 |
34.3 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.5 |
2.7 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.5 |
3.2 |
GO:0035315 |
hair cell differentiation(GO:0035315) |
| 0.5 |
3.2 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.5 |
2.6 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.5 |
3.2 |
GO:1990830 |
response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.5 |
7.8 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.5 |
2.6 |
GO:0045765 |
regulation of angiogenesis(GO:0045765) |
| 0.5 |
1.5 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.5 |
2.0 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.5 |
2.0 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) |
| 0.5 |
2.6 |
GO:0007292 |
female gamete generation(GO:0007292) |
| 0.5 |
0.5 |
GO:0014734 |
skeletal muscle hypertrophy(GO:0014734) |
| 0.5 |
2.5 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.5 |
8.6 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.5 |
2.5 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.5 |
1.5 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.5 |
3.5 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.5 |
2.5 |
GO:0034656 |
nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.5 |
10.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.5 |
1.5 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.5 |
6.5 |
GO:0010524 |
positive regulation of calcium ion transport into cytosol(GO:0010524) |
| 0.5 |
1.5 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.5 |
2.4 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.5 |
3.9 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.5 |
2.9 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.5 |
6.3 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.5 |
1.0 |
GO:0001865 |
NK T cell differentiation(GO:0001865) |
| 0.5 |
1.9 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.5 |
1.0 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.5 |
1.0 |
GO:1901159 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.5 |
8.1 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.5 |
1.4 |
GO:0046219 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.5 |
1.0 |
GO:2001258 |
negative regulation of cation channel activity(GO:2001258) |
| 0.5 |
2.8 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 0.5 |
1.9 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.5 |
3.3 |
GO:0098868 |
bone growth(GO:0098868) |
| 0.5 |
1.4 |
GO:0071467 |
cellular response to pH(GO:0071467) |
| 0.5 |
0.5 |
GO:0061430 |
bone trabecula morphogenesis(GO:0061430) |
| 0.5 |
1.4 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.5 |
1.4 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.5 |
1.8 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.5 |
6.4 |
GO:0030815 |
negative regulation of cAMP metabolic process(GO:0030815) |
| 0.5 |
4.1 |
GO:0030947 |
regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.5 |
6.3 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.5 |
9.5 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.5 |
1.8 |
GO:1990845 |
adaptive thermogenesis(GO:1990845) |
| 0.4 |
0.9 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.4 |
1.8 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.4 |
2.7 |
GO:0048014 |
Tie signaling pathway(GO:0048014) |
| 0.4 |
1.3 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.4 |
2.2 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.4 |
3.9 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.4 |
1.7 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.4 |
6.0 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.4 |
1.3 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.4 |
1.7 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.4 |
5.1 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.4 |
0.4 |
GO:0044241 |
lipid digestion(GO:0044241) |
| 0.4 |
10.8 |
GO:0007588 |
excretion(GO:0007588) |
| 0.4 |
0.4 |
GO:0046643 |
regulation of gamma-delta T cell activation(GO:0046643) |
| 0.4 |
1.2 |
GO:0045840 |
positive regulation of mitotic nuclear division(GO:0045840) |
| 0.4 |
1.2 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.4 |
2.9 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.4 |
2.9 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.4 |
0.4 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.4 |
4.5 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.4 |
1.2 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.4 |
7.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.4 |
1.2 |
GO:0007617 |
mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.4 |
2.4 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.4 |
0.8 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.4 |
4.7 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.4 |
0.8 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.4 |
1.9 |
GO:1990822 |
basic amino acid transmembrane transport(GO:1990822) |
| 0.4 |
1.1 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.4 |
1.5 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.4 |
3.7 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.4 |
7.1 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
| 0.4 |
3.0 |
GO:0003159 |
morphogenesis of an endothelium(GO:0003159) endothelial tube morphogenesis(GO:0061154) |
| 0.4 |
1.1 |
GO:0097120 |
receptor localization to synapse(GO:0097120) |
| 0.4 |
2.6 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.4 |
2.9 |
GO:0035176 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.4 |
1.1 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.4 |
1.1 |
GO:0045046 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.4 |
2.9 |
GO:2000114 |
regulation of establishment of cell polarity(GO:2000114) |
| 0.4 |
31.9 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.4 |
1.1 |
GO:0097359 |
UDP-glucosylation(GO:0097359) |
| 0.3 |
7.3 |
GO:0007368 |
determination of left/right symmetry(GO:0007368) |
| 0.3 |
0.3 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.3 |
1.4 |
GO:0003413 |
chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.3 |
3.1 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 |
4.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.3 |
14.4 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.3 |
4.1 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.3 |
3.0 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.3 |
4.0 |
GO:0003170 |
heart valve development(GO:0003170) |
| 0.3 |
3.3 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.3 |
5.9 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.3 |
1.6 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.3 |
0.6 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.3 |
3.2 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.3 |
0.3 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 0.3 |
2.9 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.3 |
8.2 |
GO:0006893 |
Golgi to plasma membrane transport(GO:0006893) |
| 0.3 |
7.6 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.3 |
5.9 |
GO:0042472 |
inner ear morphogenesis(GO:0042472) |
| 0.3 |
1.9 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
| 0.3 |
2.5 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.3 |
3.1 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.3 |
0.9 |
GO:0042551 |
neuron maturation(GO:0042551) |
| 0.3 |
4.3 |
GO:0099536 |
synaptic signaling(GO:0099536) |
| 0.3 |
2.4 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.3 |
1.2 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.3 |
1.2 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.3 |
0.6 |
GO:0014004 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.3 |
2.7 |
GO:0043691 |
reverse cholesterol transport(GO:0043691) |
| 0.3 |
2.1 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.3 |
1.8 |
GO:1900165 |
negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.3 |
0.9 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.3 |
1.8 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.3 |
1.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 |
1.2 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.3 |
0.3 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.3 |
0.9 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 |
1.4 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.3 |
0.9 |
GO:0035809 |
regulation of urine volume(GO:0035809) |
| 0.3 |
1.4 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.3 |
2.2 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.3 |
0.3 |
GO:0002673 |
regulation of acute inflammatory response(GO:0002673) |
| 0.3 |
0.3 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) paraxial mesoderm formation(GO:0048341) |
| 0.3 |
2.5 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.3 |
0.5 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.3 |
1.9 |
GO:0019935 |
cyclic-nucleotide-mediated signaling(GO:0019935) |
| 0.3 |
1.6 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.3 |
0.5 |
GO:0048814 |
regulation of dendrite morphogenesis(GO:0048814) |
| 0.3 |
0.8 |
GO:1904896 |
ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.3 |
1.3 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.3 |
1.0 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.3 |
1.0 |
GO:0031670 |
cellular response to nutrient(GO:0031670) |
| 0.3 |
1.5 |
GO:0007398 |
ectoderm development(GO:0007398) |
| 0.3 |
5.4 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.3 |
1.0 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.3 |
1.0 |
GO:0007140 |
male meiosis(GO:0007140) |
| 0.3 |
3.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.3 |
2.3 |
GO:0031573 |
intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 |
13.0 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.2 |
1.9 |
GO:0006833 |
water transport(GO:0006833) |
| 0.2 |
1.0 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.2 |
0.7 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.2 |
0.5 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.2 |
1.0 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.2 |
1.9 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.2 |
0.5 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.2 |
0.7 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.2 |
0.5 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.2 |
2.8 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.2 |
2.5 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.2 |
0.9 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.2 |
1.1 |
GO:0030207 |
chondroitin sulfate catabolic process(GO:0030207) |
| 0.2 |
0.7 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) |
| 0.2 |
0.4 |
GO:0008593 |
regulation of Notch signaling pathway(GO:0008593) |
| 0.2 |
2.4 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.2 |
0.4 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.2 |
3.5 |
GO:0019433 |
triglyceride catabolic process(GO:0019433) |
| 0.2 |
0.9 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.2 |
0.4 |
GO:0051353 |
positive regulation of oxidoreductase activity(GO:0051353) |
| 0.2 |
1.1 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.2 |
0.8 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.2 |
2.3 |
GO:1903513 |
endoplasmic reticulum to cytosol transport(GO:1903513) |
| 0.2 |
0.8 |
GO:0072402 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.2 |
6.4 |
GO:0032945 |
negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) negative regulation of leukocyte proliferation(GO:0070664) |
| 0.2 |
1.2 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.2 |
1.2 |
GO:0061025 |
membrane fusion(GO:0061025) |
| 0.2 |
1.3 |
GO:0021510 |
spinal cord development(GO:0021510) |
| 0.2 |
2.9 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.2 |
1.0 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
0.6 |
GO:0046021 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.2 |
0.2 |
GO:0060745 |
bile acid signaling pathway(GO:0038183) apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) mammary gland branching involved in pregnancy(GO:0060745) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.2 |
1.3 |
GO:0050707 |
regulation of cytokine secretion(GO:0050707) positive regulation of cytokine secretion(GO:0050715) |
| 0.2 |
4.0 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.2 |
1.8 |
GO:0006814 |
sodium ion transport(GO:0006814) |
| 0.2 |
0.5 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 |
0.2 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.2 |
1.0 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.2 |
1.4 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.2 |
0.5 |
GO:1901994 |
meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.2 |
1.8 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.2 |
0.8 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.2 |
0.8 |
GO:0032620 |
interleukin-17 production(GO:0032620) |
| 0.2 |
5.7 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) |
| 0.2 |
0.3 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.2 |
0.6 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 |
0.8 |
GO:1902659 |
hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.2 |
0.5 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
1.0 |
GO:0045109 |
intermediate filament organization(GO:0045109) |
| 0.1 |
0.7 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
3.5 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
2.6 |
GO:0070306 |
lens fiber cell differentiation(GO:0070306) |
| 0.1 |
1.9 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.1 |
2.3 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.1 |
1.5 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
2.5 |
GO:0090277 |
positive regulation of peptide secretion(GO:0002793) positive regulation of peptide hormone secretion(GO:0090277) |
| 0.1 |
4.7 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.3 |
GO:0009750 |
response to fructose(GO:0009750) negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.9 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.1 |
1.1 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.1 |
0.6 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.8 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.1 |
1.0 |
GO:0046777 |
protein autophosphorylation(GO:0046777) |
| 0.1 |
0.6 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.1 |
4.5 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 |
0.6 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.7 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
| 0.1 |
1.1 |
GO:0006536 |
glutamate metabolic process(GO:0006536) |
| 0.1 |
0.3 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.2 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.1 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 |
0.8 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.1 |
0.2 |
GO:0090177 |
establishment of planar polarity involved in neural tube closure(GO:0090177) regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
| 0.1 |
0.6 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 |
0.6 |
GO:0051155 |
positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.1 |
0.3 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
4.3 |
GO:0050907 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 |
0.5 |
GO:1990001 |
inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
0.8 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.1 |
5.2 |
GO:0048515 |
spermatid differentiation(GO:0048515) |
| 0.1 |
0.5 |
GO:0001881 |
receptor recycling(GO:0001881) |
| 0.1 |
0.8 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.1 |
0.3 |
GO:0002266 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
1.5 |
GO:0007631 |
feeding behavior(GO:0007631) |
| 0.1 |
0.6 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.1 |
0.2 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.1 |
1.2 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.1 |
1.4 |
GO:0009083 |
branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.1 |
GO:0051926 |
negative regulation of calcium ion transport(GO:0051926) |
| 0.1 |
0.8 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.1 |
0.4 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.1 |
0.2 |
GO:0001941 |
postsynaptic membrane organization(GO:0001941) |
| 0.1 |
0.3 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.0 |
0.4 |
GO:0098760 |
interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.0 |
0.5 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.0 |
0.1 |
GO:0045931 |
positive regulation of mitotic cell cycle(GO:0045931) |
| 0.0 |
0.0 |
GO:0043536 |
positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.0 |
0.1 |
GO:0032925 |
regulation of activin receptor signaling pathway(GO:0032925) |
| 0.0 |
1.8 |
GO:0031294 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 |
0.1 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.0 |
0.5 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 |
10.5 |
GO:0043547 |
positive regulation of GTPase activity(GO:0043547) |
| 0.0 |
0.1 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.0 |
0.2 |
GO:0001754 |
eye photoreceptor cell differentiation(GO:0001754) |
| 0.0 |
0.3 |
GO:0006577 |
amino-acid betaine metabolic process(GO:0006577) |
| 0.0 |
0.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.2 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.0 |
0.1 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.6 |
GO:0031214 |
biomineral tissue development(GO:0031214) |
| 0.0 |
0.1 |
GO:0046602 |
regulation of mitotic centrosome separation(GO:0046602) |
| 0.0 |
0.1 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.0 |
0.0 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.0 |
0.0 |
GO:0034599 |
cellular response to oxidative stress(GO:0034599) |
| 0.0 |
0.0 |
GO:0032803 |
regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.0 |
0.0 |
GO:0097398 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.0 |
0.3 |
GO:0030219 |
megakaryocyte differentiation(GO:0030219) |
